Jad Omran, MD, FSCAI | SCAI

Jad Omran, MD, FSCAI, is an interventional cardiologist practicing at Sharp Health Care Hospitals in San Diego, CA. Dr.Omran earned his medical degree in 2011 from Damascus University School of Medicine in Syria. This was followed by three years of internal medicine residency at the University of Missouri and three years of general cardiology fellowship, where he served as chief cardiovascular fellow, with a focus on direct patient care and clinical research. Following this, Dr.Omran completed a two-year interventional cardiology training program at the University of California in San Diego with comprehensive training in complex and high-risk coronary, peripheral and structural heart interventions, as well as mechanical circulatory support devices.

Dr.Omran's primary areas of interest are structural heart interventions, including transcatheter aortic valve replacement (TAVR), percutaneous mitral valve repair/replacement, percutaneous tricuspid valve interventions, ASD/PFO closures, as well as left atrial appendage occlusion (LAAO). Dr.Omran focuses on complex and high-risk coronary intervention, chronic total occlusions, intravascular imaging, management of cardiogenic shock, as well as management of pulmonary embolism and limb salvage cases. In addition to staying current on the latest catheter-based therapies, Dr.Omran participates in clinical research to advance the field of interventional cardiology. Inspired by recent advances in interventional and minimally invasive therapies and the wide variety of therapeutic options now available, Dr.Omran continues to work towards improving outcomes for his and all patients.

Dr.Omran serves on multiple national committees as an active member, such as the Society for Cardiovascular Angiography and Interventions (SCAI) and the American Colleague of Cardiology (ACC). He is a speaker/consultant for multiple medical device companies (Philips, Abbott, and Medtronic) and contributes to numerous talks/lectures for educational purposes. He is a Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI).